Nvidia CEO Says AGI Has Arrived With OpenAI GPT-6 Astra 
TSMC August Revenue Jumps 53% on AI Chip Demand 
Gold Prices Rise as Yen Rally Weakens Dollar 
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows 
Australia Plans New Rules Giving Users Control Over Social Media Feeds 
Oil Prices Hold Near Highs as U.S.-Iran Conflict Escalates 
U.S. Stock Futures Steady as Oil Tops $100 Ahead of Inflation Data 
Zara Owner Inditex Sales Rise 9% in August 
Nvidia Plans 2GW Australia AI Data Center Expansion by 2027 
China Exports Surge 25% in August as Trade Surplus Hits $119 Billion 
South Korea GDP Surges on Chip and AI Boom 
Fitch Eyes Japan Budget for Fiscal Discipline 
Ingenia Rejects A$1.9 Billion Warburg Pincus Takeover Bid 
Qualcomm Stock Jumps on Amazon AI Chip Deal 
U.S. Accuses Chinese AI Firms of Extracting Model Capabilities 
Apple Unveils $1,999 Foldable iPhone Duo 
Norway Core Inflation Rises to 3% in August 
Add as a preferred source on Google
SK C&C has signed a deal with Microsoft Korea for cooperation in the advancement of AI cerebral hemorrhage solutions. The former is planning to register its imaging solution on Microsoft Azure for its healthcare platform.
SK C&C said it inked the memorandum of understanding (MOU) with Microsoft Korea on Thursday, Feb. 2. It has partnered with the American tech firm so it can expand into the global market for digital healthcare solutions. The IT services unit of the SK Group is also aiming to strengthen the industry ecosystem through the deal.
As per The Korea Economic Daily, under the agreement, the Medical Insight Plus Cerebral Hemorrhage imaging medical solution that was developed by SK C&C will be filed under the Microsoft Azure Healthcare neuroradiology category which is the company's cloud platform that specializes in healthcare.
Once registered, medical clinics that would like to make use of the solution can simply buy it from the Azure Marketplace. Buyers will also be able to receive follow-up services on the platform. SK C&C will also jump into the global market by working with the in-country sales organization of Microsoft company.
"Starting with Asia and Oceania, we will actively seek out various solutions for the global healthcare market as well as customized digital IT service markets in the medical field," SK C&C's Healthcare Group's head, Yoon Dong Joon, said.
Korea Biomed Review stated that SK C&C's Medical Insight+ Brain Hemorrhage is an AI-based cerebral hemorrhage imaging solution that assesses brain CT scan images. The solution can complete the analysis within seconds. Thus, doctors are immediately informed about any bleeding or abnormalities detected. The company said that the accuracy of the software is more than 98%
SK C&C further stressed that the imaging solution software has the ability to identify even the smallest bleeding that can be missed by professional neuro-head and neck radiologists.
